Your browser doesn't support javascript.
loading
Safety and efficacy of rivastigmine in children with Down syndrome: A double blind placebo controlled trial.
Spiridigliozzi, Gail A; Hart, Sarah J; Heller, James H; Schneider, Heather E; Baker, Jane Ann; Weadon, Cathleen; Capone, George T; Kishnani, Priya S.
Affiliation
  • Spiridigliozzi GA; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
  • Hart SJ; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.
  • Heller JH; Formerly of Department of Surgery, Duke University Medical Center, Durham, North Carolina.
  • Schneider HE; Department of Neuropsychology, Kennedy Krieger Institute, Baltimore, Maryland.
  • Baker JA; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.
  • Weadon C; Down Syndrome Clinic and Research Center, Kennedy Krieger Institute, Baltimore, Maryland.
  • Capone GT; Down Syndrome Clinic and Research Center, Kennedy Krieger Institute, Baltimore, Maryland.
  • Kishnani PS; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Am J Med Genet A ; 170(6): 1545-55, 2016 06.
Article in En | MEDLINE | ID: mdl-27061338

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Down Syndrome / Rivastigmine Type of study: Clinical_trials / Diagnostic_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Am J Med Genet A Journal subject: GENETICA MEDICA Year: 2016 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Down Syndrome / Rivastigmine Type of study: Clinical_trials / Diagnostic_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Am J Med Genet A Journal subject: GENETICA MEDICA Year: 2016 Document type: Article Country of publication: United States